Callan Family Office’s Sanofi SNY Stock Holding History

Callan Family Office’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Sell	130,339 -113,203	-46%	-$5.06M	0.11%	184
2026 Q1	$11.7M	Buy	243,542 +35,530	+17%	+$1.66M	0.27%	75
2025 Q4	$10.1M	Sell	208,012 -21,265	-9%	-$1.05M	0.22%	90
2025 Q3	$10.8M	Sell	229,277 -6,245	-3%	-$301K	0.34%	54
2025 Q2	$11.4M	Buy	235,522 +163,920	+229%	+$8.38M	0.36%	52
2025 Q1	$3.97M	Buy	71,602 +362	+0.5%	+$19.6K	0.3%	74
2024 Q4	$3.44M	Buy	+71,240	New	+$3.62M	0.22%	88
2023 Q2	–	Sell	-24,800	Closed	-$1.35M	–	149
2023 Q1	$1.35M	Buy	+24,800	New	+$1.21M	0.33%	46

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Callan Family Office's SNY Position: Q2 2026 in Review

Callan Family Office reduced its Sanofi (SNY) stake by 46% in Q2 2026, selling an estimated $5.06M and leaving 130,339 shares worth $5.56M. The position accounts for 0.11% of the portfolio, ranked #184.

Callan Family Office first reported a position in SNY in Q1 2023 and has held it in 8 quarters since. The position peaked at $11.7M in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Callan Family Office held 130,339 shares of Sanofi worth $5.56M as of Q2 2026.
Callan Family Office sold 113,203 Sanofi shares in Q2 2026, an estimated $5.06M.
Sanofi made up 0.11% of Callan Family Office's portfolio in Q2 2026, its #184 holding.
Callan Family Office first reported a position in Sanofi in Q1 2023 and has held it in 8 quarters since.
Callan Family Office's Sanofi position peaked at $11.7M in Q1 2026.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.